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FEATURES OF METABOLIC AND HEMODYNAMIC INDICATORS IN 
OBESE PATIENTS WITH RESISTANT HYPERTENSION
Anna Shalimova1, V. Psarova2, M. Kochuieva3. 1L.T. Malaya Therapy National 
Institute of the NAMS of Ukraine, Kharkiv, UKRAINE, 2Sumy State Univer-
sity, Sumy, UKRAINE, 3Kharkiv Medical Academy of Postgraduate Education, 
Kharkiv, UKRAINE
Objective: To establish the features of metabolic and hemodynamic parameters 
in obese patients with true and pseudo-resistant arterial hypertension (AH).
Design and method: The study included 200 patients with AH grade II and 
obesity I-II classes (age 45-55 years). Patients were initially prescribed dual an-
tihypertensive therapy (ACEI and CCB). Those patients who did not reach target 
blood pressure (BP) levels after 3 months on dual therapy were additionally as-
signed a third antihypertensive drug (indapamide). Of the 98 patients who were 
assigned triple therapy, 48 patients did not reach target BP levels: 27 patients 
had pseudo-resistant AH (due to low compliance with treatment and insuffi cient 
adherence to the physician’s instructions to ensure adequate levels of physical 
activity), and 21 patients had true resistant AH (did not have target BP levels with 
triple antihypertensive therapy and suffi cient physical activity). These patients 
were additionally prescribed spironolactone. The effectiveness of the treatment 
in all groups was evaluated 6 months after the start of antihypertensive therapy.
Results: Comparative assessment of obese patients in the presence and absence 
of resistant AH after 6 months of therapy showed that, unlike patients without 
resistance, individuals with resistant AH differed more pronounced cardiovascu-
lar remodeling and metabolic disorders, greater dysbalance of oxidative stress-
antioxidant protection, greater proinfl ammatory activity and higher activity of 
the RAAS. When performing a comparative evaluation of the indicators in pa-
tients with pseudo-resistant and true resistant AH, it was found that patients with 
true resistance differed from pseudo-resistant patients with signifi cantly lower 
(p=0.0229) body mass index (BMI). In addition, in the absence of differences 
in BP levels, cardiovascular remodeling, lipid and carbohydrate profi les, patients 
with true resistance had signifi cantly higher levels of aldosterone (p=0.0449), 
higher activity of oxidative stress system (malondialdehyde, p=0.0055 and diene 
conjugates, p=0.0299), lower levels of general antioxidant protection (p=0.0004), 
higher adiponectin levels (p=0.0000), and lower leptin level (p=0.0001), com-
pared to pseudo-resistant patients
Conclusions: Obese patients with true resistance differed from pseudo-resistant 
patients with signifi cantly lower BMI, higher aldosterone level, higher activity of 
the oxidative stress system, lower activity of the antioxidant protection system, 
higher adiponectin level, and lower leptin level.
DRUG-RESISTANT HYPERTENSION IN PRIMARY ALDOSTERONISM
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Objective: Drug-resistant arterial hypertension can derive from unrecognized 
forms of secondary hypertension of which primary aldosteronism (PA) is one 
of the most common. While available data suggest a high prevalence of PA in 
patients with resistant hypertension (RH), its rate in such population is unclear. 
This study sought to establish the rate of RH in patients with PA and the blood 
pressure outcome and resistance to treatment after adrenalectomy PA-RH patients 
subtyped by adrenal vein sampling (AVS).
Design and method: Data from consecutive patients with unambiguous diag-
nosis of PA and seeking surgical cure, submitted to AVS in 19 tertiary referral 
centers located in Asia, Australia, Europe, and North America, were collected in 
an observational prospective registry from 2000 to 2015. Blood pressure outcome 
and resistance to treatment by the American Heart Association 2018 criteria or 
a local clinical defi nition were the main study outcomes. Inclusion criteria were 
age > 18 years, indication to perform AVS following current guidelines, center’s 
agreement to participate and approval of the local Ethics Committee.
Results: Of 1625 enrolled PA patients, 73.7% had conclusive information on 
presence or absence of resistant hypertension. Of these, 20.1% were judged to 
have RH, a rate that raised to 49.5% according to the clinical defi nition of each 
center lead investigator. RH was about twice as common in men as in women (p< 
1x10-4). Fifty-three percent of the PA patients with RH underwent surgery, which 
resolved resistance to drug treatment in all.
Conclusions: RH is a common presentation of PA in consecutive patients seek-
ing surgical cure; AVS-guided adrenalectomy allowed to resolve resistance of 
high blood pressure to treatment. Hence, the optimal management of patients with 
PA and RH requires subtyping with adrenal vein sampling.
ARE SUBJECTIVE MEASURES THE ANSWER TO ASSESS 
PHYSICAL ACTIVITY ON A DAILY BASIS CLINICAL PRACTICE IN 
PATIENTS WITH RESISTANT HYPERTENSION?
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Objective: Physical activity is a vital sign for cardiovascular health. However, 
several factors, such as the duration of the protocol, equipment cost, and need for 
qualifi ed professionals make the assessment of physical activity with objective 
measures impractical on a daily basis in a clinical practice. Hence, this study aims 
to examine the association between subjective and objective physical activity lev-
els in patients with resistant hypertension.
Design and method: Sixty-six patients (age: 59±1.0 yrs; gender: 50.7% men; 
BMI: 29.8±0.6 kg/m2; number of antihypertensive medications: 4.6±0.1) were 
recruited. Outcome measures included clinical data, blood pressure, daily physi-
cal activity (questionnaire and accelerometry). Physical activity was objectively 
measured over a 7-day period with an accelerometer and sedentary time, and time 
spent at light and moderate-to-vigorous physical activity (MVPA) was computed. 
Physical activity was also subjectively (self-assessment) assessed from 2 ques-
tions regarding moderate and vigorous physical activity. The association between 
the objective and subjective physical activity measurement was tested, and the 
McNemar test was employed to examine differences between measures.
Results: The proportion of patients reporting at least 20 min of continuous, 
moderate intensity physical activity per week was 60.9% (n=39) compared to the 
27% (n=17) that were actually registered by the accelerometer (p<0.05). The dif-
ference was also higher in the category of vigorous physical activity, where 1 pa-
tient (1.6%) did at least 20 minutes of vigorous activity, while 22 patients (34.4%) 
actually reported to have done it (p<0.05). Self-reported moderate and vigorous 
physical activity were not correlated with objectively measured moderate and vig-
orous activity (rho=0.116, p=0.379; rho=-0.087, p=0.508, respectively).
Conclusions: Our fi ndings highlight that despite being a valid, easy and inexpen-
sive solution for assessing physical activity levels in adults with resistant hyper-
tension, the subjectively (self- reported) measures are overestimating the physical 
activity levels. Findings suggest that self-reported physical activity should be in-
terpreted with caution in adults with resistant hypertension and complemented by 
accelerometry data when possible.
CHRONIC KIDNEY DISEASE IN PATIENTS WITH RESISTANCE 
HYPERTENSION AND ACHIEVEMENT OF TARGET BLOOD 
PRESSURE
Oksana Rekovets, Olena Torbas, Svitlana Kushnir, Galina Primak, Nina Krushy-
nska, Vladimir Granich, Yuriy Sirenko. Institute of Cardiology, Kyiv, UKRAINE
Objective: Glomerular fi ltration rate (eGFR) drop in patients with resistant hy-
pertension and how different factors can affect on achievement of target blood 
pressure in patients with resistant hypertension and chronic kidney disease 
(CKD). To evaluate factors related with achievement of target blood pressure in 
patients with resistant hypertension and CKD.
Design and method: We included 1134 patients who taken 3 or more antihyper-
tensive drugs: fi rst group (n= 877) patients with RH and eGFR (CKD-EPI) >= 60 
ml/min/1.73 m2 a mean age of 53.5±7.1 years, and second group (n=257) patients 
with RH and eGFR (CKD-EPI) < 60 ml/min/1.73 m2 a mean age 66.1±8.5 years, 
SBP 172.8±8.2 and DBP 101.2±6.3mmHg. Patients with secondary arterial hy-
pertension was excluded.
Results: 513 patients (58.5%) with eGFR >= 60 ml/min/1.73 m2 and achieve-
ment target offi ce BP and 233 patients (41.5%) not achievement target offi ce BP. 
140 patients (54.5%) with eGFR < 60 ml/min/1.73 m2 and achievement target 
offi ce BP and 117 patients (45.5%) not achievement target offi ce BP. Patients 
with CKD-EPI >=60 ml/min/1.73 m2 and achievement BP had higher blood 
renin (324.5±23.3) ng/l vs not achievement BP (23.2±3.5) ng/l (p<0.05). Patients 
